OpenLB
Open Library of Bioscience
Advanced Search
European journal of hospital pharmacy : science and practice
Feb 22, 2024;31 (2): 178-179.

Correspondence on 'Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series'.

Xiaohua Xiao Zhou, Hong Jian Ji
Author Information
  1. Xiaohua Xiao Zhou: Department of Nephrology, Yancheng Third People's Hospital, Yancheng, Jiangsu, China zhouxiaohua1983@126.com. ORCID
  2. Hong Jian Ji: School of Pharmacy, Jiangsu Vocational College of Medicine, Yancheng, China. ORCID
PMID: 36737228 DOI: 10.1136/ejhpharm-2023-003701

Abstract

No abstract text available.

Keywords

CLINICAL MEDICINE COVID-19 DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS Drug Administration Routes Drug Monitoring Kidney Failure, Chronic Kidney Transplantation

References

  1. Int J Mol Sci. 2022 Apr 19;23(9): [PMID: 35562875]
  2. Eur J Hosp Pharm. 2024 Feb 22;31(2):175-177 [PMID: 36535689]

MeSH Term

Humans
Ritonavir
COVID-19
Tacrolimus
Kidney Transplantation
COVID-19 Drug Treatment
Lactams
Leucine
Nitriles
Proline

Chemicals

Ritonavir
nirmatrelvir
Tacrolimus
Lactams
Leucine
Nitriles
Proline
Letter
Article has an altmetric score of 2

Word Cloud

Created with Highcharts 10.0.0DrugKidneyCorrespondence'Managementnirmatrelvir/ritonavirtacrolimusinteractionkidneytransplantrecipientsinfectedCOVID-19:three-caseseries'CLINICALMEDICINECOVID-19DRUG-RELATEDSIDEEFFECTSANDADVERSEREACTIONSAdministrationRoutesMonitoringFailureChronicTransplantation

Similar Articles

Cited By

No available data.